Endo-3-Boc-3-azabicyclo[3.1.0]hexane-6-carboxylic acid is a bicyclic heterocyclic compound featuring a fused cyclopropane and pyrrolidine ring system. It contains both a carboxylic acid group and a tert-butoxycarbonyl (Boc)-protected secondary amine, making it a versatile chiral building block. The rigid, three-dimensional structure imparted by the bicyclic scaffold is of significant interest in medicinal chemistry. This compound is primarily utilized as a key intermediate in pharmaceutical research and development. Its constrained geometry is valuable for designing drug candidates that target central nervous system (CNS) disorders and other therapeutic areas where modulating receptor or enzyme activity with high selectivity is crucial. The presence of orthogonal protecting groups (Boc and carboxylic acid) allows for selective functionalization and incorporation into more complex molecular architectures. As a bifunctional synthon, it serves as a precursor for synthesizing various pharmacologically active molecules. Its application underscores the importance of structurally unique, chiral intermediates in modern drug discovery programs aimed at improving drug-like properties such as potency, metabolic stability, and blood-brain barrier penetration.